Eric Burak
2021
In 2021, Eric Burak earned a total compensation of $3M as Chief Scientific Officer at Fusion Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,164 |
|---|---|
| Option Awards | $2,308,284 |
| Salary | $458,549 |
| Other | $23,599 |
| Total | $2,956,597 |
Burak received $2.3M in option awards, accounting for 78% of the total pay in 2021.
Burak also received $166.2K in non-equity incentive plan, $458.5K in salary and $23.6K in other compensation.
Rankings
In 2021, Eric Burak's compensation ranked 4,484th out of 12,412 executives tracked by ExecPay. In other words, Burak earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,484 out of 12,412 | 64th |
Division Manufacturing | 1,844 out of 5,498 | 67th |
Major group Chemicals And Allied Products | 768 out of 2,374 | 68th |
Industry group Drugs | 683 out of 2,095 | 67th |
Industry Biological Products, Except Diagnostic Substances | 172 out of 452 | 62nd |
Source: SEC filing on April 29, 2022.
Burak's colleagues
We found two more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2021.